Entrada Therapeutics Inc 2026年季度报告

For the quarterly period ended March31, 2026 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ENTRADA THERAPEUTICS, INC. (Exact name of registrant as specified in its charter)____________________________ Registrant’s telephone number, including area code: (857) 520-9158 Securities registered pursuant to Section 12(b) of the Act: Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (orfor such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YesNo Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of thischapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). YesNo Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See thedefinitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accountingstandards provided pursuant to Section 13(a) of the Exchange Act. Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YesNo As of April30, 2026, the registrant had 38,820,616 shares of common stock, $0.0001 par value per share, outstanding. TABLE OF CONTENTS Part IFinancial InformationItem 1.Financial Statements (Unaudited)8Condensed Consolidated Balance Sheets8Condensed Consolidated Statements of Operations and Comprehensive Loss9Condensed ConsolidatedStatements of Stockholders’ Equity10Condensed Consolidated Statements of Cash Flows11Notes to Condensed Consolidated Financial Statements12Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations22Item 3.Quantitative and Qualitative Disclosures about Market Risk36Item 4.Controls and Procedures36Part IIOther InformationItem 1.Legal Proceedings37Item 1A.Risk Factors37Item 2.Unregistered Sales of Equity Securities and Use of Proceeds100Item 3.Defaults Upon Senior Securities100Item 4.Mine Safety Disclosures100Item 5.Other Information100Item 6.Exhibits102Signatures103 We own various U.S. federal trademark applications and unregistered trademarks, including our company name and logo, that we use inconnection with the operation of our business. This Quarterly Report on Form 10-Q ("Quarterly Report") may also contain trademarks, service marksand trade names of third parties, which are the property of their respective owners. Our use or display of third parties’ trademarks, service marks, tradenames or products in this Quarterly Report is not intended to, and does not imply a relationship with, or endorsement or sponsorship by us. Solely forconvenience, the trademarks, service marks and trade names referred to in this Quarterly Report may appear without the ®, TM or SM symbols, butthe omission of such references is not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights orthat the applicable owner of these trademarks, service marks and trade names will not assert, to the fullest extent under applicable law, its rights. From time to time, we may use our website or our LinkedIn profile at www.linkedin.com/company/entradatx to distribute materialinformation. Our financial and other material information is routinely posted to and accessible on the Investors Relations section of our website,available at www.entradatx.com. Investors are encouraged to review the Investors Relations section of our website because we may post materialinformation on that site that is not otherwise disseminated by us. Information that is contained in and can be accessed through our website or ourLinkedIn profile is not incorporated into, and does not form a part of, this Quarterly Report. CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This Quarterly Report on Form 10-Q (“Quarterly Report”) contains express or implied forward-looking statements within the meaning of thePrivate Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E ofthe Securities Exchange Act of 1934, as amended (the “Exchange Act”). These statements are based on our management’s current beliefs,expectations and assumptions about future events, conditions and results and on information currently available to us. These statement